Other: hydroxychloroquine/chloroquine (DrugBank: Chloroquine, Hydroxychloroquine)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
46 | 悪性関節リウマチ | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04347798 (ClinicalTrials.gov) | September 2020 | 13/4/2020 | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | IMPACT RAPPORT: IMPact of Antimalarials on Covid Infections: a Case Control sTudy of RAPPORT | Covid-19 Infection;Rheumatoid Arthritis;Psoriatic Arthritis;Hydroxychloroquine | Other: Hydroxychloroquine/Chloroquine | University of Alberta | NULL | Enrolling by invitation | 18 Years | N/A | All | 500 | Canada |